2022. Gentiopicroside ameliorates lipopolysaccharide-induced acute kidney injury by inhibiting TLR4/NF-κB signaling in mice model. Journal of Pharmaceutical Negative Results. 13, 4 (Oct. 2022), 135–145. DOI:https://doi.org/10.47750/pnr.2022.13.04.018.